Pauline Labbé

Pauline Labbé

Auto-generated profile, based on publicly available information

Pauline Labbé

CHU Nantes, Institut du Thorax, Nantes, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DDDamien Duval
Damien Duval
PLPauline Labbé
Pauline Labbé
LBLéa Bureau
Léa Bureau
TTThierry Le Tourneau
Thierry Le Tourneau
RNRussell Norris
Russell Norris
JMJean Merot
Jean Merot
Although the genetic basis of mitral valve prolapse (MVP) has now been clearly established, the molecular and cellular mechanisms involved in the pathological processes associated to a specific mutation often remain to be determined. The FLNA gene (encoding Filamin A; FlnA) was the first gene associated to non-syndromic X-linked myxomatous valvular dystrophy, but the impacts of the mutations on its function remain un-elucidated. Here, using the first repeats (1–8) of FlnA as a bait in a yeast two-hybrid screen, we identified the tyrosine phosphatase PTPN12 (PTP-PEST) as a specific binding partner of this region of FlnA protein. In addition, using yeast two-hybrid trap assay pull down and co-immunoprecipitation experiments, we showed that the MVP-associated FlnA mutations (G288R, P637Q, H743P) abolished FlnA/PTPN12 interactions. PTPN12 is a key regulator of signaling pathways involved in cell-extracellular matrix (ECM) crosstalk, cellular responses to mechanical stress that involve integrins, focal adhesion transduction pathways, and actin cytoskeleton dynamics. Interestingly, we showed that the FlnA mutations impair the activation status of two PTPN12 substrates, the focal adhesion associated kinase Src, and the RhoA specific activating protein p190RhoGAP. Together, these data point to PTPN12/FlnA interaction and its weakening by FlnA mutations as a mechanism potentially involved in the physiopathology of FlnA-associated MVP.

1 January 2016 in Archives of Cardiovascular Diseases Supplements
Verified
Journal Article
Closed access
ADAntoine Jobbe Duval
Antoine Jobbe Duval
ARAntoine Rimbert
Antoine Rimbert
PLPauline Labbe
Pauline Labbe
CCCaroline Cueff
Caroline Cueff
SLSimon Lecointe
Simon Lecointe
TTThierry le Tourneau
Thierry le Tourneau

1 April 2014 in Archives of Cardiovascular Diseases Supplements
Verified
Journal Article
Closed access
PLPauline Labbé
Pauline Labbé
FKFlorence Kyndt
Florence Kyndt
TTThierry Le Tourneau
Thierry Le Tourneau
Stéphane ZaffranStéphane Zaffran
Stéphane Zaffran
CDCécile Duplaà
Cécile Duplaà
JMJean Merot
Jean Merot

1 April 2016 in Archives of Cardiovascular Diseases Supplements
Verified
Journal Article
Closed access
PLPauline Labbé
Pauline Labbé
ARAntoine Rimbert
Antoine Rimbert
AJAntoine Jobbe-Duval
Antoine Jobbe-Duval
SLSimon Lecointe
Simon Lecointe
SSSolena Le Scouarnec
Solena Le Scouarnec
JMJean Merot
Jean Merot